Peptides for gym performance: what TikTok leaves out

What did @rokkzillaa actually say?

The creator describes a four-to-six week cycle of IGF-1 LR3, dosed three times per week, taken in the morning. They acknowledge timing flexibility, saying "some people use it pre-workout, some people use it post-workout, really depending on you and what your goals are." That's the full extent of the protocol advice given. No specific doses were mentioned, no stacking was discussed, and the framing was casual, personal, and vague enough that it reads more like a journal entry than a protocol recommendation. Still, 64,700 views means a lot of people are taking notes.

IGF-1 LR3 is a synthetic, long-acting analog of insulin-like growth factor 1. It is not approved by the FDA for human use in the context being described here. That context matters before we go any further.

Does the science back this up?

Partially, but the evidence base is thinner than the peptide community tends to admit. IGF-1 LR3 has real pharmacological activity, but most human data comes from clinical populations, not healthy athletes.

IGF-1 itself plays a well-documented role in muscle protein synthesis and satellite cell activation. The LR3 variant has a longer half-life than native IGF-1, roughly 20-30 hours versus minutes, because it has reduced binding affinity for IGF-binding proteins (Baxter, 2014, Growth Hormone and IGF Research). That extended activity is why it is popular in performance contexts.

The four-to-six week cycle length the creator mentions does have some loose rationale behind it. Prolonged IGF-1 receptor stimulation can downregulate receptor sensitivity over time, so cycling is used to mitigate that. However, the optimal cycle length in healthy humans is not established in controlled trials. The three-times-per-week frequency and morning timing are also not supported by any published human protocol. They are community conventions, not clinical findings.

What did they get wrong (or right)?

Credit where it is due: the creator did not claim IGF-1 LR3 would cure anything. They did not push a specific dose. They acknowledged individual variation in timing, which is honest. That relative restraint puts this video above a lot of what circulates in the peptide space.

What they got wrong, or at least glossed over, is significant. Saying it is "really depending on you" without flagging the actual risks of IGF-1 LR3 misuse is a meaningful omission. IGF-1 signaling is associated with cell proliferation pathways. Elevated IGF-1 has been epidemiologically linked to increased risk of certain cancers, including colorectal and prostate cancer (Renehan et al., 2004, Lancet). That does not mean the peptide causes cancer, but it means the "hit the next level" framing needs a serious asterisk.

There is also the hypoglycemia risk. IGF-1 has insulin-like effects and can cause significant drops in blood glucose, particularly around dosing. The creator mentions morning use without any note of this, which is a real safety gap.

What should you actually know?

IGF-1 LR3 is not a regulated therapeutic peptide in the same category as, say, a compounded BPC-157 product from a licensed pharmacy. It is largely sourced from research chemical suppliers with inconsistent quality control and no manufacturing oversight for human use. What is in the vial is not always what is on the label.

The performance-enhancing rationale has biological plausibility. IGF-1 does promote muscle hypertrophy and recovery through mTOR pathway activation and satellite cell proliferation (Schiaffino and Mammucari, 2011, Nature Reviews Molecular Cell Biology). But plausibility is not the same as a proven, safe protocol for a healthy 20-something filming themselves in a gym.

If you are interested in peptide-based optimization through a legal, medically supervised route, the conversation starts with a licensed provider who can assess your baseline IGF-1 levels, not a TikTok comment section. Self-administered IGF-1 LR3 from an unverified source carries real risks that a 60-second video will never fully capture.